Douglas Galasko

Active 1990–2025

296
Papers
86,941
Citations
135
h-index
282
i10-index

Citations

Citations per year for Douglas Galasko1977: 2 citations1986: 1 citations1988: 2 citations1990: 2 citations1991: 11 citations1992: 20 citations1993: 28 citations1994: 53 citations1995: 62 citations1996: 117 citations1997: 122 citations1998: 184 citations1999: 178 citations2000: 281 citations2001: 240 citations2002: 263 citations2003: 311 citations2004: 244 citations2005: 276 citations2006: 371 citations2007: 454 citations2008: 616 citations2009: 667 citations2010: 652 citations2011: 829 citations2012: 893 citations2013: 927 citations2014: 942 citations2015: 955 citations2016: 936 citations2017: 1,035 citations2018: 1,003 citations2019: 2,903 citations2020: 3,236 citations2021: 3,144 citations2022: 2,971 citations2023: 2,510 citations2024: 3,970 citations2025: 2,275 citations2026: 101 citations1978–1985: no citations, so these years are not shown1987: no citations, so this year is not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 10,965 citing papers, 25.7% of this breakdownUnited Kingdom: 4,024 citing papers, 9.4% of this breakdownChina: 2,718 citing papers, 6.4% of this breakdownGermany: 2,309 citing papers, 5.4% of this breakdownItaly: 2,160 citing papers, 5.1% of this breakdownCanada: 1,717 citing papers, 4% of this breakdownSweden: 1,694 citing papers, 4% of this breakdownFrance: 1,486 citing papers, 3.5% of this breakdownSpain: 1,461 citing papers, 3.4% of this breakdownNetherlands: 1,424 citing papers, 3.3% of this breakdownAustralia: 1,348 citing papers, 3.2% of this breakdownJapan: 1,132 citing papers, 2.6% of this breakdown
0%25.7%Other 24%

Fields

  • Medicine67.4%
  • Neuroscience13.9%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Computer Science1.4%
  • Psychology0.9%
  • Immunology and Microbiology0.8%
  • Other3.2%

Topics

  • Alzheimer's disease research and treatments13.5%
  • Dementia and Cognitive Impairment Research11.1%
  • Parkinson's Disease Mechanisms and Treatments6.3%
  • Neuroinflammation and Neurodegeneration Mechanisms3.2%
  • Amyotrophic Lateral Sclerosis Research2.6%
  • Neurological disorders and treatments2.3%
  • Other61%

Coauthors

All papers

Open in search
  1. Diagnosis and management of dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Álex Iranzo, Kejal Kantarci, Daniel Kaufer, Walter A. Kukull, Virginia M.‐Y. Lee, James B. Leverenz, Simon J.G. Lewis, Carol F. Lippa, Angela Lunde, Mario Masellis, Eliezer Masliah, Pamela J. McLean, Brit Mollenhauer, Thomas J. Montine, Emilio Moreno, Etsuro Mori, Melissa E. Murray, John T. O’Brien, Sotoshi Orimo, Ronald B. Postuma, Shankar Ramaswamy, Owen A. Ross, David P. Salmon, Andrew Singleton, Angela Taylor, Alan Thomas, Pietro Tiraboschi, Jon B. Toledo, John Q. Trojanowski, Debby W. Tsuang, Zuzana Walker, Masahito Yamada, Kenji Kosaka - Neurology 2017 cited by 4,446

  2. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandra E. Black, Marsel Mesulam, Sandra Weıntraub, Brad C. Dickerson, Janine Diehl‐Schmid, Florence Pasquier, Vincent Deramecourt, Florence Lebert, Yolande A.L. Pijnenburg, Tiffany W. Chow, Facundo Manes, Jordan Grafman, Stefano F. Cappa, Morris Freedman, Murray Grossman, Bruce L. Miller - Brain 2011 cited by 5,270

  3. The Parkinson Progression Marker Initiative (PPMI)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keith A. Hawkins, Jamie L. Eberling, Deborah W. Brooks, David Russell, Laura Leary, Stewart A. Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David G. Standaert, Stephanie Guthrie, Robert A. Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Hegeman Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly A. Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltán Mari, Melissa Gerstenhaber, David J. Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor D. Grachev, Kim P. Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony W. Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor - Progress in Neurobiology 2011 cited by 1,915

  4. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2023 cited by 693

  5. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2021 cited by 1,009

  6. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yaakov Stern, Philip Scheltens, Jeffrey L. Cummings - The Lancet Neurology 2014 cited by 3,296

  7. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 1,030

  8. Diagnosis and management of dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Kosaka, V.M.Y. Lee, Andrew J. Lees, Irene Litvan, Elisabet Londos, Oscar L. López, Satoshi Minoshima, Y Mizuno, J. A. Molina, Elizabeta B. Mukaetova‐Ladinska, Florence Pasquier, R. H. Perry, Jörg B. Schulz, John Q. Trojanowski, Masahito Yamada - Neurology 2005 cited by 5,057

  9. Research criteria for the diagnosis of prodromal dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the prodromal DLB Diagnostic Study Group - Neurology 2020 cited by 777

  10. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2007 cited by 4,384

  11. The ageing systemic milieu negatively regulates neurogenesis and cognitive function

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2011 cited by 1,793

  12. Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer Disease & Associated Disorders 2018 cited by 515

  13. Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eli Shobin, Hugo Vanderstichele, Michael W. Weiner, David Wilson, Oskar Hansson - Nature Reviews Neurology 2024 cited by 264

  14. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert C. Green, Ekaterina Rogaeva, Peter St George‐Hyslop, Steven E. Arnold, Robert C. Barber, Thomas G. Beach, Eileen H. Bigio, James D. Bowen, Adam Boxer, James R. Burke, Nigel J. Cairns, Chris Carlson, Regina M. Carney, Steven L. Carroll, Helena C. Chui, David G. Clark, Jason J. Corneveaux, Carl W. Cotman, Jeffrey L. Cummings, Charles DeCarli, Steven T. DeKosky, Ramon Diaz‐Arrastia, Malcolm Dick, Dennis W. Dickson, William G. Ellis, Kelley M. Faber, Kenneth B. Fallon, Martin R. Farlow, Steven H. Ferris, Matthew P. Frosch, Douglas Galasko, Mary Ganguli, Marla Gearing, Daniel H. Geschwind, Bernardino Ghetti, John R. Gilbert, Sid Gilman, Bruno Giordani, Jonathan D. Glass, John H. Growdon, Ronald L. Hamilton, Lindy E. Harrell, Elizabeth Head, Lawrence S. Honig, Christine M. Hulette, Bradley T. Hyman, Gregory A. Jicha, Lee‐Way Jin, Nancy Johnson, Jason Karlawish, Anna Karydas, Jeffrey Kaye, Ronald Kim, Edward H. Koo, Neil W. Kowall, James J. Lah, Allan I. Levey, Andrew P. Lieberman, Oscar L. López, Wendy J. Mack, Daniel Marson, Frank Martiniuk, Deborah C. Mash, Eliezer Masliah, Wayne C. McCormick, Susan M. McCurry, Andrew McDavid, Ann C. McKee, Marsel Mesulam, Bruce L. Miller and 55 more - Nature Genetics 2011 cited by 2,014

  15. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher H. van Dyck, Lawrence S. Honig, Raquel Sánchez‐Valle, William S. Brooks, Serge Gauthier, Douglas Galasko, Colin L. Masters, Jared R. Brosch, Ging‐Yuek Robin Hsiung, Suman Jayadev, Maïté Formaglio, Mario Masellis, Roger Clarnette, Jérémie Pariente, Bruno Dubois, Florence Pasquier, Clifford R. Jack, Robert A. Koeppe, Peter J. Snyder, Paul Aisen, Ronald G. Thomas, Scott Berry, Barbara Wendelberger, Scott W. Andersen, Karen C. Holdridge, Mark A. Mintun, R. Yaari, John R. Sims, Monika Baudler, Paul Delmar, Rachelle S. Doody, Paulo Fontoura, Caroline Giacobino, Geoffrey A. Kerchner, Randall J. Bateman, the Dominantly Inherited Alzheimer Network–Trials Unit, Maïté Formaglio, Susan L. Mills, Jérémie Pariente, Christopher H. van Dyck - Nature Medicine 2021 cited by 365

  16. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jane C. Burns, Murray A. Raskind, Steven H. Ferris, Gregory A. Jicha, M. Quiceno, Thomas O. Obisesan, Paul B. Rosenberg, Daniel Weintraub, Karl Kieburtz, Bruce L. Miller, Richard J. Kryscio, G. Alexopoulis - Neurology 2015 cited by 699

  17. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zane Jaunmuktane, Douglas Galasko, Isabel Santana, Pentti J. Tienari, Liisa Myllykangas, Minna Oinas, Nigel J. Cairns, John C. Morris, Glenda M. Halliday, Vivianna M. Van Deerlin, John Q. Trojanowski, Maurizio Grassano, Andrea Calvo, Gabriele Mora, Antonio Canosa, Gianluca Floris, Ryan C. Bohannan, Francesca Brett, Ziv Gan‐Or, Joshua T. Geiger, Anni Moore, Patrick May, Rejko Krüger, David S. Goldstein, Grisel Lopez, Nahid Tayebi, Ellen Sidransky, Anthony R. Sotis, Gauthaman Sukumar, Camille Alba, Nathaniel M. Lott, Elisa McGrath Martinez, Meila Tuck, Jatinder Singh, Dagmar Bačíková, Xijun Zhang, Daniel Hupalo, Adelani Adeleye, Matthew D. Wilkerson, Harvey B. Pollard, Lucy Norcliffe‐Kaufmann, Jose‐Alberto Palma, Horacio Kaufmann, Vikram G. Shakkottai, Matthew Perkins, Kathy L. Newell, Thomas Gasser, Claudia Schulte, Francesco Landi, Erika Salvi, Daniele Cusi, Eliezer Masliah, Ronald C. Kim, Chad A. Caraway, Edwin S. Monuki, Maura Brunetti, Ted M. Dawson, Liana S. Rosenthal, Marilyn S. Albert, Olga Pletnikova, Juan C. Troncoso, Margaret E. Flanagan, Qinwen Mao, Eileen H. Bigio, Eloy Rodríguez‐Rodríguez, Jon Infante, Carmen Lage, Isabel González Aramburu, Pascual Sánchez‐Juan, Bernardino Ghetti and 68 more - Nature Genetics 2021 cited by 481

  18. Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates

    Authors: , , , , , , , , , , , - Journal of Alzheimer s Disease 2014 cited by 755

  19. Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC

    Authors: , , , , , , , , , - Acta Neuropathologica Communications 2018 cited by 431

  20. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2014 cited by 675

  21. Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tatiana M. Foroud, Jonathan L. Haines, Richard Mayeux, Margaret A. Pericak‐Vance, Julie A. Schneider, John Q. Trojanowski, Lindsay A. Farrer, Gerard D. Schellenberg, Gary W. Beecham, Thomas J. Montine, Gyungah Jun, Erin L. Abner, Perrie M. Adams, Marilyn S. Albert, Roger L. Albin, Liana G. Apostolova, Steven E. Arnold, Sanjay Asthana, Craig Atwood, Clinton T. Baldwin, Robert C. Barber, Lisa L. Barnes, Sandra Barral, James T. Becker, Duane Beekly, Eileen H. Bigio, Thomas D. Bird, Deborah Blacker, Bradley F. Boeve, James D. Bowen, Adam Boxer, James R. Burke, Jeffrey M. Burns, Nigel J. Cairns, Laura B. Cantwell, Chuanhai Cao, Chris Carlson, Cynthia M. Carlsson, Regina M. Carney, Minerva M. Carrasquillo, Helena C. Chui, David H. Cribbs, Elizabeth Crocco, Carlos Cruchaga, Charles DeCarli, Malcolm Dick, Rachelle S. Doody, Ranjan Duara, Nilüfer Ertekin‐Taner, Denis A. Evans, Kelley Faber, Thomas Fairchild, Kenneth B. Fallon, David W. Fardo, Martin R. Farlow, Steven H. Ferris, Douglas Galasko, Marla Gearing, Daniel H. Geschwind, Valentina Ghisays, Alison Goate, Neill R. Graff‐Radford, Robert C. Green, John H. Growdon, Håkon Håkonarson, Ronald L. Hamilton, Kara L. Hamilton‐Nelson, Lindy E. Harrell, Lawrence S. Honig, Ryan M. Huebinger and 92 more - Nature Communications 2020 cited by 490

  22. Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration

    Authors: , , , , , , , , , , , , , , , , - Brain 2022 cited by 228

  23. The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers

    Authors: , , , , , , , , , , , , - Alzheimer Disease & Associated Disorders 2006 cited by 973

  24. Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Agronin, Francisco Lopera, Lisa Delano‐Wood, Stéphanie Bombois, Richard Lévy, Madhav Thambisetty, Jean Georges, David T. Jones, Helen Lavretsky, Jonathan M. Schott, Jennifer R. Gatchel, Sandra Swantek, Paul Newhouse, Howard Feldman, Giovanni B. Frisoni - JAMA Neurology 2024 cited by 352